Expand SLDB Menu
SLDB MENU

SLDB Latest Press Releases

-- December 16, 2025 --

Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services Globe Newswire 4:51 PM

-- December 8, 2025 --

Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum Globe Newswire 8:00 AM

-- December 1, 2025 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM
Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich's Ataxia Globe Newswire 8:00 AM

-- November 17, 2025 --

Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101 Globe Newswire 8:00 AM

-- November 11, 2025 --

Solid Biosciences to Participate at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- November 4, 2025 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 3, 2025 --

Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions Globe Newswire 4:05 PM

-- October 30, 2025 --

Solid Biosciences to Participate at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- October 1, 2025 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM
Solid Biosciences to Present at Upcoming Scientific Meetings Globe Newswire 8:00 AM

-- September 25, 2025 --

Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting Globe Newswire 8:00 AM

-- September 23, 2025 --

Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101 Globe Newswire 8:00 AM

-- August 28, 2025 --

Solid Biosciences to Participate at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 12, 2025 --

Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates Globe Newswire 4:07 PM

-- August 1, 2025 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 8:00 AM

-- July 24, 2025 --

Citizens JMP Remains a Buy on Solid Biosciences (SLDB) TipRanks 5:28 AM

-- July 23, 2025 --

Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes